Expert Review on Poliovirus Immunity and Transmission-Reference-Cited by-同舟云学术

Expert Review on Poliovirus Immunity and Transmission

Published:2012-07-15 Issue:4 Volume:33 Page:544-605
ISSN:0272-4332
Container-title:Risk Analysis
language:en
Short-container-title:Risk Analysis

Author:

Duintjer Tebbens Radboud J.¹,Pallansch Mark A.²,Chumakov Konstantin M.³,Halsey Neal A.⁴,Hovi Tapani⁵,Minor Philip D.⁶,Modlin John F.⁷,Patriarca Peter A.⁸,Sutter Roland W.⁹,Wright Peter F.⁷,Wassilak Steven G. F.¹⁰,Cochi Stephen L.¹⁰,Kim Jong-Hoon¹,Thompson Kimberly M.¹

Affiliation:

1. Kid Risk, Inc.; P.O. Box 590129; Newton; MA; USA

2. National Center for Immunization and Respiratory Diseases, Division of Viral Diseases; Centers for Disease Control and Prevention; Atlanta; GA; USA

3. Center for Biologics Evaluation and Research, Food and Drug Administration; Rockville; MD; USA

4. Department of International Health; Johns Hopkins Bloomberg School of Public Health; Baltimore; MD; USA

5. National Institute for Health and Welfare (THL); Helsinki; Finland

6. National Institute of Biological Standards and Control, Health Protection Agency; South Mimms; Potters Bar; Hertfordshire; UK

7. Dartmouth-Hitchcock Medical Center; Lebanon; NH; USA

8. Biologics Consulting Group, Inc.; Bethesda; MD; USA

9. Polio Eradication Initiative; World Health Organization; Geneva; Switzerland

10. Global Immunization Division, Center for Global Health; Centers for Disease Control and Prevention; Atlanta; GA; USA

Publisher

Wiley

Subject

Physiology (medical),Safety, Risk, Reliability and Quality

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1539-6924.2012.01864.x/fullpdf

Reference147 articles.

1. Pre-eradication vaccine policy options for poliovirus infection and disease control;Thompson;Risk Analysis,2013

2. Policy decision options during the first 5 years following certification of polio eradication;Sangrujee;Medscape General Medicine,2003

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An automated assay platform for the evaluation of antiviral compounds against polioviruses;Journal of Virological Methods;2024-09

2. Trade-offs of different poliovirus vaccine options for outbreak response in the United States and other countries that only use inactivated poliovirus vaccine (IPV) in routine immunization;Vaccine;2024-02

3. Immunity Agent-Based Model (IABM) for epidemiological systems;Chaos, Solitons & Fractals;2023-11

4. Oral polio vaccine stockpile modeling: insights from recent experience;Expert Review of Vaccines;2023-09-29

5. Oral and fecal polio vaccine excretion following bOPV vaccination among Israeli infants;Vaccine;2023-06